BMC Gastroenterology

Papers
(The H4-Index of BMC Gastroenterology is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Colonic bacterial diversity and dysbiosis in active microscopic colitis as compared to chronic diarrhoea and healthy controls: effect of polyethylene glycol after bowel lavage for colonoscopy112
Intensive surveillance endoscopy for multiple gastrointestinal tumors in a patient with constitutional mismatch repair deficiency: case report90
Development and validation of comprehensive nomograms from the SEER database for predicting early mortality in metastatic rectal cancer patients86
Enhancing surgical precision: unveiling the impact of preoperative colonoscopy in anal fistula patients82
Analysis of clinical features and prognostic factors in patients with hepatic hydrothorax: a single-center study from China65
Anorectal manometry for the diagnosis of pelvic floor disorders in patients with hypermobility spectrum disorders and hypermobile Ehlers-Danlos syndrome62
Construction and validation of a survival prognostic model for stage III hepatocellular carcinoma: a real-world, multicenter clinical study55
The rs9953490 polymorphism of DAL-1 gene is associated with gastric cancer risk in the Han population in Northeast China52
The prognostic value of systemic inflammation response index in digestive system carcinomas: a systematic review and meta-analysis51
PPARγ activation attenuates neonatal CRD-induced visceral pain sensitization and anxiety in male rats by alleviating oxidative stress43
Association between neutrophil-albumin ratio and ultrasound-defined metabolic dysfunction-associated fatty liver disease in U.S. adults: evidence from NHANES 2017–201843
Diagnostic yield of esophagogastroduodenoscopy, colonoscopy, and small bowel endoscopy in Thai adults with chronic diarrhea42
Clinical applicability of a new scoring system for population-based screening and risk factors of gastric cancer in the Wannan region39
Machine learning for temporary stoma after intestinal resection in surgical decision-making of Crohn’s disease36
Prevalent osteoporosis and fracture risk in patients with hepatic cirrhosis: a systematic review and meta-analysis35
Natural killer cell activity is a risk factor for the recurrence risk after curative treatment of hepatocellular carcinoma33
Weight-adjusted waist circumference index with hepatic steatosis and fibrosis in adult females: a cross-sectional, nationally representative study (NHANES 2017–2020)31
Advanced lung cancer inflammation index: a key predictor of hepatic steatosis and fibrosis severity30
Development and evaluation of a predictive model of upper gastrointestinal bleeding in liver cirrhosis29
The diagnostic criteria for psychosomatic research-revised (DCPR-R) in a National China multicenter cohort of patients with irritable bowel syndrome and overlapping gastroesophageal reflux disease28
Association between avoidant/restrictive food intake disorder risk, dietary attitudes and behaviors among Chinese patients with inflammatory bowel disease: a cross-sectional study28
Incidence, risk factors, and predictive modeling of stoma site incisional hernia after enterostomy closure: a multicenter retrospective cohort study28
m1A methylation modification patterns and metabolic characteristics in hepatocellular carcinoma27
Plasma and fecal zonulin are not altered by a high green leafy vegetable dietary intervention: secondary analysis of a randomized control crossover trial26
Normalization of γ-glutamyl transferase levels is associated with better metabolic control in individuals with nonalcoholic fatty liver disease26
Prognostic analysis of hepatocellular carcinoma based on cuproptosis -associated lncRNAs26
ARL9 is upregulated and serves as a biomarker for a poor prognosis in colon adenocarcinoma26
Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals26
Validation and prognostic value of EZ-ALBI score in patients with intermediate-stage hepatocellular carcinoma treated with trans-arterial chemoembolization26
0.06002402305603